SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork…
AzurRx BioPharma (NASDAQ: AZRX) has activated additional clinical trial sites for its trial of MS1819 in cystic fibrosis. The company specializes…
Exro Technologies (TSX.V: XRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for…
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process quality assurance software for the commercial 3D metal printing industry, today…
Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, achieved a 44% increase in revenues…
The Movie Studios (OTC: MVES), a vertically integrated motion-picture production and distribution company, is looking to be a major player…
Grey Cloak Tech (OTC: GRCK) (soon to be Healthy Extracts Inc.), together with its growing portfolio of wholly owned subsidiaries,…
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, today announced that its Bonum Health subsidiary has…
CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working…
Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s…